Skip to main content
. Author manuscript; available in PMC: 2019 Nov 22.
Published in final edited form as: Cell Rep. 2019 Oct 29;29(5):1351–1368.e5. doi: 10.1016/j.celrep.2019.09.060

Table 1.

Stable RNPs Identified by DIF-FRAC

Gene Names Complex Name Function Soluble without RNA?a Disease Links CORUM/hu.MAPb rna.MAP ID DIF-FRAC Plot RNP Classc References
CLASP1 N/A microtubule binding yes N/A no/yes 3807 apo-stable Efimov et al., 2007
CLASP2 microtubule dynamics
DAXX DAXX-TP53 complex transcription repression yes pancreatic neuroendocrine tumors yes/no 4518 apo-stable Zhao et al., 2004
TP53 glioblastoma multiforme Dyer et al., 2017
adrenocortical tumors
DRG1 Drg1/Dfrp1 complex microtubule binding yes lung adenocarcinoma no/no 4096 apo-stable Lu et al., 2016
ZC3H15 microtubule polymerase Schellhaus et al., 2017
GTPase Ishikawa et al., 2009
BOD1L1 SET1A/SET1B complexes histone methyltransferase yes Fanconi anemia yes/yes 2005, 3307 apo-stable Vedadi et al., 2017
SETD1A transcription regulation mixed-lineage leukemia Higgs et al., 2015
CXXC1*,d Brown et al., 2017
ASH2L
RBBP5
WDR5
NIPSNAP1* N/A vesicular transport no inflammatory pain no/yes 5822 apo-stable Okuda-Ashitaka et al., 2012
NIPSNAP2* Yamamoto et al., 2017
RPA1 replication protein A complex single-stranded DNA binding yes Werner syndrome yes/yes 3204 apo-stable Machwe et al., 2011
RPA2* DNA metabolism Fan and Pavletich, 2012
RPA3*,d
FLII FLII-LRRFIP1 complex transcriptional activation yes prostate cancer no/yes 3626 apo-stable Wilson et al., 1998
LRRFIP1 actin binding Wang et al., 2016
BAZ1A* WCRF complex chromatin remodeling No intellectual disability yes/no 2105 compositional Bochar et al., 2000
SMARCA5 Zaghlool et al., 2016
MICU1*,d MICU1-MICU2 heterodimer calcium ion transport yes myopathy with extrapyramidal signs yes/yes 4318 structural Logan et al., 2014
MICU2*,d
NOC4L N/A ribosome processing and biogenesis no recurrent pregnancy loss no/yes 4220 structural Suzuki et al., 2018
NOP14
SFPQ PSF-p54(nrb) complex splicing factor yes intellectual disability yes/yes 327 apo-stable Bladen et al., 2005
NONO DNA recombination Mircsof et al., 2015
RRP12 N/A rRNA processing no N/A no/yes 5795 structural Zemp et al., 2009
RIOK2
H1FX
SAP18 N/A SAP18 is involved in RNA processing and splicing no N/A no/yes 6027 structural Davis et al., 2010
NKTR
CCDC9 NKTR is involved in protein peptidyl-prolyl isomerization
LARP4 N/A translation regulation yes N/A no/yes 3327 apo-stable Yang et al., 2011
LARP4B Schäffler et al., 2010
XRCC5 Ku antigen complex DNA damage and repair yes systemic lupus erythematosus yes/no 2930 apo-stable Spagnolo et al., 2006
XRCC6
SAMM50*,d N/A protein transport yes N/A no/yes 1450 apo-stable
MTX3*,d
MTX2*
SLC25A5 prohibitin apoptosis yes N/A yes/no 204 apo-stable Kasashima et al., 2006
VDAC2
PHB
HAX1*
PHB2*
TPP2 tripeptidyl-peptidase II serine protease yes muscle wasting yes/no apo-stable Schönegge et al., 2012
obesity Rockel et al., 2012
cancer
*

Previously unreported RNA-associated proteins identified by DIF-FRAC (see Table S1).

a

Insolubility in the absence of RNA is inferred by an increase in apparent molecular weight of the complex upon RNA digestion or a complete disappearance of signal. This is consistent with the RNP’s being solubilized by RNA, as suggested by Maharana et al. (2018).

b

Evidence for all or some protein complex subunits interacting in CORUM or hu.MAP.

c

RNP classes apo-stable, structural, and compositional, as described in Figure 4.

d

Previously unreported RNA-associated proteins that are above the 5% FDR cutoff.